Afya (NASDAQ:AFYA) Sees Large Volume Increase – Should You Buy?

Posted by Francis Steltz on Sep 24th, 2026

Shares of Afya Limited (NASDAQ:AFYA – Get Free Report) saw unusually-high trading volume on Thursday . Approximately 115,736 shares traded hands during mid-day trading, a decline of 8% from the previous session’s volume of 126,422 shares.The stock last traded at $13.52 and had previously closed at $13.58.

Trending Headlines about Afya

Here are the key news stories impacting Afya this week:

Positive Sentiment: Strategic merger creates a larger education platform. Afya and Yduqs signed a binding agreement to combine their Brazilian higher-education operations, creating a company valued at approximately R$9 billion. The transaction would broaden Afya’s scale beyond medical education and strengthen its position in Brazil. Afya and Yduqs merger announcement
Positive Sentiment: Potential cost and operating synergies. JPMorgan reportedly sees as much as R$2.8 billion in potential synergies, offering a possible boost to earnings and cash generation if the companies successfully integrate their operations. Afya is expected to own approximately 69.3% of the combined company, giving it majority control. JPMorgan merger scenarios
Positive Sentiment: Shareholder distribution included in the deal terms. Reports indicate the transaction includes a share exchange and approximately R$750 million in dividends, which could provide near-term value to shareholders. Merger share exchange and dividends
Neutral Sentiment: Potential Nasdaq listing change. Reports suggest the combined structure could result in Afya leaving Nasdaq while Yduqs remains listed in Brazil. This may alter the company’s investor base, liquidity and valuation framework, although the final listing arrangements remain important details for investors. Potential Afya Nasdaq delisting
Negative Sentiment: Analyst-screen pressure adds to caution. Zacks added AFYA to its Rank #5 “Strong Sell” list, potentially weighing on sentiment. Investors may also remain concerned about regulatory approvals, integration costs, transaction dilution and whether the projected synergies can be realized. Zacks Strong Sell list

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on AFYA shares. Wall Street Zen upgraded Afya from a “hold” rating to a “buy” rating in a report on Saturday, September 5th. Zacks Research cut Afya from a “hold” rating to a “strong sell” rating in a research note on Friday, August 21st. Weiss Ratings downgraded shares of Afya from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, July 31st. Bank of America reiterated a “neutral” rating on shares of Afya in a research note on Thursday, June 11th. Finally, Bradesco Corretora raised shares of Afya to an “outperform” rating and set a $17.00 target price on the stock in a report on Thursday. One analyst has rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $17.75.

Read Our Latest Analysis on Afya

Afya Trading Down 1.0%

The firm has a 50-day moving average of $14.02 and a 200 day moving average of $14.34. The company has a current ratio of 2.20, a quick ratio of 2.20 and a debt-to-equity ratio of 0.39. The stock has a market capitalization of $1.26 billion, a price-to-earnings ratio of 8.20, a PEG ratio of 1.51 and a beta of 0.35.

Afya (NASDAQ:AFYA – Get Free Report) last released its earnings results on Friday, August 14th. The company reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.03. Afya had a return on equity of 17.58% and a net margin of 20.55%.The firm had revenue of $187.80 million during the quarter, compared to the consensus estimate of $189.62 million. As a group, equities analysts predict that Afya Limited will post 1.86 EPS for the current fiscal year.

Insider Buying and Selling at Afya

In other news, VP Gomiero Mirella Basolli sold 10,000 shares of the firm’s stock in a transaction on Friday, June 26th. The stock was sold at an average price of $14.80, for a total value of $148,000.00. Following the completion of the sale, the vice president owned 34,530 shares of the company’s stock, valued at $511,044. This trade represents a 22.46% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, VP Lélio de Souza, Jr. sold 36,204 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $15.00, for a total value of $543,060.00. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 87,745 shares of company stock worth $1,314,175. Company insiders own 0.80% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of AFYA. Public Employees Retirement System of Ohio acquired a new stake in Afya in the 2nd quarter worth approximately $67,000. Engineers Gate Manager LP bought a new position in shares of Afya in the second quarter valued at approximately $325,000. Banco BTG Pactual S.A. bought a new position in shares of Afya in the fourth quarter valued at approximately $462,000. Finally, Swedbank AB lifted its stake in shares of Afya by 170.3% in the fourth quarter. Swedbank AB now owns 189,200 shares of the company’s stock worth $2,916,000 after buying an additional 119,200 shares during the last quarter. Institutional investors own 88.02% of the company’s stock.

Afya Company Profile

(Get Free Report)

Afya Limited is a Brazilian medical education and technology company that operates an integrated platform for physicians and medical students. The company provides education and professional development throughout the medical career cycle, from undergraduate training and residency preparation to continuing medical education and specialization programs.

Afya’s offerings include medical schools, preparatory courses, postgraduate and continuing education programs, digital learning tools, and clinical practice technologies.